DK0811068T3 - Humane DNase I varianter - Google Patents

Humane DNase I varianter

Info

Publication number
DK0811068T3
DK0811068T3 DK95912611T DK95912611T DK0811068T3 DK 0811068 T3 DK0811068 T3 DK 0811068T3 DK 95912611 T DK95912611 T DK 95912611T DK 95912611 T DK95912611 T DK 95912611T DK 0811068 T3 DK0811068 T3 DK 0811068T3
Authority
DK
Denmark
Prior art keywords
variants
human dnase
actin
relates
resistant
Prior art date
Application number
DK95912611T
Other languages
Danish (da)
English (en)
Inventor
Steven Shak
Robert A Lazarus
Jana S Ulmer
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22248728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0811068(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0811068T3 publication Critical patent/DK0811068T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/12Mucolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95912611T 1995-02-24 1995-02-24 Humane DNase I varianter DK0811068T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/002366 WO1996026278A1 (en) 1995-02-24 1995-02-24 HUMAN DNase I VARIANTS

Publications (1)

Publication Number Publication Date
DK0811068T3 true DK0811068T3 (da) 2003-03-10

Family

ID=22248728

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95912611T DK0811068T3 (da) 1995-02-24 1995-02-24 Humane DNase I varianter

Country Status (22)

Country Link
EP (1) EP0811068B1 (ru)
JP (1) JPH11505408A (ru)
AT (1) ATE230027T1 (ru)
AU (1) AU720635B2 (ru)
BG (1) BG64061B1 (ru)
BR (1) BR9510323A (ru)
CA (1) CA2210871C (ru)
CZ (1) CZ288633B6 (ru)
DE (1) DE69529235T2 (ru)
DK (1) DK0811068T3 (ru)
ES (1) ES2188653T3 (ru)
HU (1) HU223272B1 (ru)
MX (1) MX9706428A (ru)
NO (1) NO326612B1 (ru)
PL (1) PL180773B1 (ru)
PT (1) PT811068E (ru)
RU (1) RU2215787C2 (ru)
SI (1) SI9520153B (ru)
SK (1) SK283850B6 (ru)
UA (2) UA66749C2 (ru)
WO (1) WO1996026278A1 (ru)
ZA (1) ZA961419B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK284191B6 (sk) * 1995-02-24 2004-10-05 Genentech, Inc. Aktín-rezistentný variant humánnej DNázy I
US6391607B1 (en) 1996-06-14 2002-05-21 Genentech, Inc. Human DNase I hyperactive variants
US7118901B2 (en) 2002-12-18 2006-10-10 Roche Diagnostics Operations, Inc. Recombinant bovine pancreatic desoxyribonuclease I with high specific activity
EP1433842B1 (en) 2002-12-18 2011-01-05 Roche Diagnostics GmbH Recombinant bovine pancreatic desoxyribonuclease I with high specific activity
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE358176T1 (de) * 1988-12-23 2007-04-15 Genentech Inc Menschliche dnase
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I

Also Published As

Publication number Publication date
UA66749C2 (en) 2004-06-15
SK114797A3 (en) 1998-02-04
SK283850B6 (sk) 2004-03-02
CZ288633B6 (cs) 2001-08-15
NO326612B1 (no) 2009-01-19
PT811068E (pt) 2003-04-30
ZA961419B (en) 1997-08-22
HUT77422A (hu) 1998-04-28
AU720635B2 (en) 2000-06-08
WO1996026278A1 (en) 1996-08-29
AU1970395A (en) 1996-09-11
BG101846A (en) 1998-07-31
ES2188653T3 (es) 2003-07-01
BG64061B1 (bg) 2003-11-28
CA2210871C (en) 2009-04-07
ATE230027T1 (de) 2003-01-15
RU2215787C2 (ru) 2003-11-10
JPH11505408A (ja) 1999-05-21
BR9510323A (pt) 1997-11-11
SI9520153A (sl) 1998-06-30
DE69529235D1 (de) 2003-01-30
CZ267797A3 (cs) 1998-01-14
UA65523C2 (en) 2004-04-15
EP0811068B1 (en) 2002-12-18
EP0811068A1 (en) 1997-12-10
NO973876L (no) 1997-10-24
PL321890A1 (en) 1997-12-22
MX9706428A (es) 1997-11-29
NO973876D0 (no) 1997-08-22
SI9520153B (sl) 2004-10-31
HU223272B1 (hu) 2004-04-28
DE69529235T2 (de) 2003-09-04
CA2210871A1 (en) 1996-08-29
PL180773B1 (pl) 2001-04-30

Similar Documents

Publication Publication Date Title
DK0910647T3 (da) Human DNase i hyperaktive varianter
ATE330967T1 (de) An her2 bindende peptidverbindungen
IL141021A (en) Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases
WO1996034953A3 (en) Cd16-ii variants
EP1071443A4 (en) ISOLATED PEPTIDES CORRESPOND THE NY-ESO-1 AMINO ACID SEQUENCES AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES AND THEIR USE
DK1082131T3 (da) Immunoregulator
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
WO1998011234A3 (en) Human protein kinases
FI972170A (fi) Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, näitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö
DK0811068T3 (da) Humane DNase I varianter
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
ATE278011T1 (de) Human dnase ii
MX9706429A (es) Variantes de dnasa i humana.
CA2242562A1 (en) Human dnase resistant to actin inhibition